Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Disease Name: Thrombophilia Inheritance: Autosomal Dominant (AD) Chromosome Number, Genomic Coordinates (Location): 1, 1: 169,511,953-169,586,631 Gene on Chromosome Location: 1q24.2 Protein Name: Auto-prothrombin IIA Protein Function: A zymogen (an inactive precursor to a digestive enzyme) that serves as the proteolytic component of the anticoagulant complex for the selective inactivation of factors VA and VIIA (compounds that contribute the conversion of physical cell states), with Protein S, that contribute to anticoagulant activity. Anticoagulant activity limits coagulation of red blood cells in which the red blood cell liquefies into a thick impenetrable gel in certain blood vessels (venous and arterial thrombosis representing vein and artery, Anatomy of deep vein thrombosis that explains the respectively) until the termination of blood loss requires coagulation existence of detached blood clots that contribute to the creation of an impenetrable red blood gel that at the wound site. is the essence of an increased risk of the formation of blood clots in the blood vessels, namely the veins (less serious) and arteries (more serious). Introduction of Prognosis, Onset and Symptoms of Thrombophilia https://ghr.nlm.nih.go v/art/large/deepvenous-thrombosisdvt.jpeg Having an increased risk of blood clotting as the cause of the primary symptoms for this autosomal dominant genetic disease, the onset of thrombophilia can be described with protein C deficiency, as deep venous/arterial thrombosis depicts. The Protein C, known as Auto-prothrombin IIA, is the anticoagulation protein that is a blood plasma protein reliant on Vitamin K. Blood clotting is the main cause of the symptoms associated with the disease and as the prognosis suggests, the mainstream symptom is related towards chest pain, shortness of breath, and if untreated, pulmonary embolism (blockage of blood flow to the lungs through the arteries), unless if a rare life-threatening blood clotting disorder called Purpura Fulminans occurs during infancy where blood clots form in the branches of miniscule blood vessels. Death will rapidly set and even if treated, the reoccurrence of the disease will occur due to the severity of the resistance of Auto-prothrombin IIA. The protein C when deprived of the existence in the blood plasma from the poor response to this protein, derives Blood clot due to reinforced towards the existence of the risk of blood clotting. Thrombophilia stems directly gel surrounding the red blood cells at the site of the from this protein as coagulation in the blood vessels known as the arteries (rarely) blood vessel, a condition of and veins (commonly) suggests. intravascular thrombosis. http://www.scientistlive.com/sites/scient istlive/files/styles/article/public/6049_image_one-_PR.jpg?itok=ea0aEJkC ‘ Healthy Deoxyribonucleic Acid Sequence (Sequence of the Wild Type): Nucleotide Mutation Site Affected Protein Site Type of Mutation in Genome Healthy Amino Acid Sequence (Wild Type Sequence): Conclusion: The Blood clotting is the main cause of the symptoms associated with the disease and as the prognosis suggests, the mainstream symptom is related towards chest pain and shortness of breath. This means that Thrombophilia is certainly a very dangerous and deadly disease. Bibliography: http://medicine.kln.ac.lk/depts/pathology/images/blood_module/Thrombophilia.jpg